anmelden
BX Swiss TOP 30 CHF
1.398,62
PKT
+31,19
PKT
+2,28
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.06.17 | Roche buy | Jefferies & Company Inc. | |
| 16.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 16.06.17 | Holcim buy | S&P Capital IQ | |
| 15.06.17 | Nestlé Underperform | Credit Suisse Group | |
| 15.06.17 | UBS Sell | S&P Capital IQ | |
| 15.06.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 15.06.17 | Nestlé buy | Goldman Sachs Group Inc. | |
| 15.06.17 | Nestlé buy | S&P Capital IQ | |
| 14.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 13.06.17 | UBS overweight | Morgan Stanley | |
| 13.06.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 13.06.17 | Roche overweight | Barclays Capital | |
| 09.06.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 09.06.17 | Givaudan Hold | Deutsche Bank AG | |
| 09.06.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 09.06.17 | UBS buy | Goldman Sachs Group Inc. | |
| 08.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.06.17 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 08.06.17 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
| 08.06.17 | Swiss Re kaufen | Robert W. Baird & Co. Incorporated | |
| 07.06.17 | Roche overweight | JP Morgan Chase & Co. | |
| 07.06.17 | Swiss Re Outperform | Macquarie Research | |
| 07.06.17 | Nestlé Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.06.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.06.17 | Novartis Underweight | Morgan Stanley | |
| 06.06.17 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
| 06.06.17 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 06.06.17 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.06.17 | Roche buy | Deutsche Bank AG | |
| 06.06.17 | Roche Hold | Kepler Cheuvreux | |
| 06.06.17 | Roche Reduce | HSBC | |
| 02.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.06.17 | Novartis Underweight | Barclays Capital | |
| 02.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 01.06.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 01.06.17 | Novartis buy | Jefferies & Company Inc. | |
| 26.05.17 | Nestlé buy | UBS AG | |
| 26.05.17 | UBS verkaufen | S&P Capital IQ | |
| 25.05.17 | UBS kaufen | Barclays Capital | |
| 25.05.17 | Roche Conviction Buy | Goldman Sachs Group Inc. |